Login

AUXILIUM PHARMACEUTICALS INC 4 SEC Filings

Filed On Filing
02 Feb 2015 Form 4: Flynn James E, 10% owner and 4 others

Disposed of 6,267,382 shares (Tender Offer)

30 Jan 2015 Form 4: Wills Alan, EVP, Corporate Development

Disposed of 30,743 shares (Other Transaction) ($1.12M) · Disposed of 101,625 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($3.71M)

30 Jan 2015 Form 4: Tursi James Patrick, Chief Medical Officer

Disposed of 32,634 shares (Other Transaction) · Disposed of 128,688 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($4.7M) · Disposed of 12,500 Nonqualified Employe Stock Option (Right to Buy) (Other Transaction) ($457K)

30 Jan 2015 Form 4: Saik Andrew, CFO

Disposed of 10,000 shares (Other Transaction) ($365K) · Disposed of 165,000 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($6.03M)

30 Jan 2015 Form 4: Koven Andrew I, EVP, CAO, GC and Secretary

Disposed of 38,721 shares (Other Transaction) ($1.41M) · Disposed of 193,725 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($7.08M)

30 Jan 2015 Form 4: Jobes Elizabeth Varki, Chief Compliance Officer

Disposed of 13,767 shares (Other Transaction) ($503K) · Disposed of 44,950 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($1.64M)

30 Jan 2015 Form 4: Glickman Mark A, EVP - Sales and Marketing

Disposed of 27,911 shares (Other Transaction) ($1.02M) · Disposed of 57,250 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($2.09M) · Disposed of 31,200 Nonqualified Employee Stock Option (Right To Buy) (Other Transaction) ($1.14M)

30 Jan 2015 Form 4: Armstrong Jennifer Lou, Senior Vice President, HR

Disposed of 14,874 shares (Other Transaction) ($543K) · Disposed of 47,188 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($1.72M)

30 Jan 2015 Form 4: Adams Adrian, Director

Disposed of 217,778 shares (Other Transaction) · Disposed of 795,500 Nonqualified Employee Stock Option (Right to Buy) (Other Transaction) ($29.1M)

30 Jan 2015 Form 4: Mckee William, Director

Disposed of 10,000 shares (Other Transaction) ($365K) · Disposed of 60,000 Nonqualified Stock Option (Right to Buy) (Other Transaction) ($2.19M)

30 Jan 2015 Form 4: Lurker Nancy, Director

Disposed of 10,000 shares (Other Transaction) ($365K) · Disposed of 5,000 Nonqualified Stock Option (Right to Buy) (Other Transaction) ($183K)

30 Jan 2015 Form 4: Friedman Paul A, Director

Disposed of 10,361 shares (Other Transaction) · Disposed of 25,000 Nonqualified Stock Option (Right to Buy) (Other Transaction) ($913K)

30 Jan 2015 Form 4: Fetzer Oliver, Director

Disposed of 19,197 shares (Other Transaction) · Disposed of 20,000 Nonqualified Stock Option (Right to Buy) (Other Transaction) ($731K)

30 Jan 2015 Form 4: Classon Rolf A, Director

Disposed of 10,260 shares (Other Transaction) · Disposed of 55,000 Nonqualified Stock Option (Right to Buy) (Other Transaction) ($2.01M)

30 Jan 2015 Form 4: Brandt Peter C., Director

Disposed of 25,000 shares (Other Transaction) · Disposed of 45,000 Nonqualified Stock Option (Right to Buy) (Other Transaction) ($1.64M)

05 Jan 2015 Form 4: Classon Rolf A, Director

Received 260 shares as a grant or award ($8.94K)

08 Dec 2014 Form 4: Mckee William, Director

Received 15,000 shares by exercise or conversion ($459K) · Sold 18,000 shares ($612K)

08 Dec 2014 Form 4: Lurker Nancy, Director

Received 25,000 shares by exercise or conversion ($492K) · Sold 32,430 shares ($1.1M)

08 Dec 2014 Form 4: Adams Adrian, Director

Received 40,000 shares by exercise or conversion ($696K) · Sold 40,000 shares ($1.36M)

08 Dec 2014 Form 4: Friedman Paul A, Director

Received 20,000 shares by exercise or conversion ($369K) · Sold 20,000 shares ($673K) · Sold 9,689 shares ($328K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support